Filing Details
- Accession Number:
- 0001127602-21-018780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-02 18:00:30
- Reporting Period:
- 2021-05-28
- Accepted Time:
- 2021-06-02 18:00:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1473812 | A. Brett Wall | 710 Medtronic Parkway Lc300 Minneapolis MN 55432 | Evp & Pres Neuroscience | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2021-05-28 | 12,300 | $47.00 | 31,315 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2021-05-28 | 7,355 | $126.59 | 23,960 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2021-06-01 | 2,473 | $128.07 | 21,487 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-05-28 | 12,300 | $0.00 | 12,300 | $47.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-12-02 | 2023-12-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This balance increased by 300 shares due to exempt transactions such as dividend reinvestment.
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.